The Center for Ethics and Law in Biomedicine (CELAB) was established in 2005 based on the recognition of a new and increasingly developing interdisciplinary field: the ethical, legal and social implications of biotechnology. CELAB has primarily focused on responding to emerging data protection and intellectual property issues in biomedical law and working towards a better international coordination of regulatory policies in these fields. The Center operates an online biolaw-database and organizes and participates in several international research and policy networks. In various research projects the Center explores social, cultural, ethical and legal aspects of biobank, stem cell research, genetics, human reproduction, nanotechnology, organ transplantation, and regenerative medicine.
October 17, 2016